Trends in Short- and Long-Term ST-Segment-Elevation Myocardial Infarction Prognosis Over 3 Decades: A Mediterranean
Cosme García-García1,2, Teresa Oliveras1, Jordi Serra1
1Heart Institute Hospital Universitari Germans Trias i Pujol Badalona Spain.
Insights
Outcomes for ST-segment-elevation myocardial infarction (STEMI) have significantly improved over 30 years, with reduced mortality and fewer in-hospital complications. However, reducing primary ventricular fibrillation remains a critical challenge in STEMI care.
Area of Science:
- Cardiology
- Public Health
- Clinical Research
Background:
- Coronary artery disease is a leading cause of death.
- ST-segment-elevation myocardial infarction (STEMI) outcomes have improved, but prognosis requires ongoing analysis.
- Long-term trends in STEMI prognosis are crucial for understanding disease management evolution.
Purpose of the Study:
- To analyze in-hospital, 28-day, and 1-year outcomes for STEMI patients.
- To assess temporal trends in STEMI prognosis over three decades using registry data.
- To identify improvements and persistent challenges in STEMI management.
Main Methods:
- Analysis of 7589 consecutive STEMI patients from the Ruti-STEMI registry (1989-2017).
- Patients were stratified into five distinct time periods.
- Cox regression was used to compare mortality and complication trends across periods.
Main Results:
- A significant decline in 28-day mortality (10.4% to 6.0%) and 1-year mortality (11.7% to 9.0%) was observed.
- Multivariable analysis showed a 40% reduction in 28-day mortality and 24% in 1-year mortality.
- In-hospital complications like postinfarct angina, ventricular tachycardia, and pericarditis decreased significantly; primary ventricular fibrillation showed no significant trend.
Conclusions:
- STEMI in-hospital complications and mortality rates (28-day and 1-year) have markedly decreased over the past 30 years.
- Significant improvements in STEMI prognosis are evident.
- Reducing ischemia-driven primary ventricular fibrillation remains a key challenge in STEMI management.
Abstract:
Background Coronary artery disease remains a major cause of death despite better outcomes of ST-segment-elevation myocardial infarction (STEMI). We aimed to analyze data from the Ruti-STEMI registry of in-hospital, 28-day, and 1-year events in patients with STEMI over the past 3 decades in Catalonia, Spain, to assess trends in STEMI prognosis. Methods and Results Between February 1989 and December 2017, a total of 7589 patients with STEMI were admitted consecutively. Patients were grouped into 5 periods: 1989 to 1994 (period 1), 1995 to 1999 (period 2), 2000 to 2004 (period 3), 2005 to 2009 (period 4), and 2010 to 2017 (period 5). We used Cox regression to compare 28-day and 1-year STEMI mortality and in-hospital complication trends across these periods. Mean patient age was 61.6±12.6 years, and 79.3% were men. The 28-day all-cause mortality declined from period 1 to period 5 (10.4% versus 6.0%; P<0.001), with a 40% reduction after multivariable adjustment (hazard ratio [HR], 0.6; 95% CI, 0.46-0.80; P<0.001). One-year all-cause mortality declined from period 1 to period 5 (11.7% versus 9.0%; P=0.001), with a 24% reduction after multivariable adjustment (HR, 0.76; 95% CI, 0.60-0.98; P=0.036). A significant temporal reduction was observed for in-hospital complications including postinfarct angina (-78%), ventricular tachycardia (-57%), right ventricular dysfunction (-48%), atrioventricular block (-45%), pericarditis (-63%), and free wall rupture (-53%). Primary ventricular fibrillation showed no significant downslope trend. Conclusions In-hospital STEMI complications and 28-day and 1-year mortality rates have dropped markedly in the past 30 years. Reducing ischemia-driven primary ventricular fibrillation remains a major challenge.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease III: Clinical Manifestations
Myocarditis III: Medical Management
